who shouldn't take glp 1 The Science Behind GLP-1 Medications: Facts vs Hype GLP-1 Drugs and Eating Disorders:

Anyone who produces a lower-than-normal amount of stomach acid, resulting in a certain kind of bacteria growing in the stomach and using up all your B12

nausea at elevated doses (anecdotal, human) injection site discomfort (anecdotal) Where to source Research use only Affiliate link we may earn a commission at no extra cost to you

4d), among which six ferroptosis-inhibiting genes (Slc7a11, Slc40a1, Gclm, Fth1, Gclc, and Gss) were upregulated, one ferroptosis-promoting gene (Slc39a14) was downregulated, and one ferroptosis-promoting gene (Hmox1) was upregulated

doi: 10.1101/cshperspect.a016295 154 GermolecDRShipkowskiKAFrawleyRPEvansE

Recent research highlights a significant concern for users of glucagon-like peptide-1 receptor agonists (GLP-1RAs), commonly prescribed in diabetes management

The PI3K/Akt/mTOR pathway is another critical target of inflammatory modulation (Lu et al., 2023)